Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying These Stocks

ICAHN CAPITAL LPUsually, we have to wait until six to seven weeks after the end of a quarter to see what hedge funds have been buying. The exception is when they take on (or change) a large enough position that requires disclosure with the SEC- investors can learn about these transactions fairly quickly. Here are five stocks that hedge funds have been buying recently:

Carl Icahn isn’t letting his recent investment in Netflix consume all his attention: he’s been adding back shares of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) that he had sold last year. The PC and video game industry has been suffering as more consumers move towards mobile-based entertainment, but Take Two has been seeing better numbers at least temporarily. Its top and bottom lines were up in its most recent quarter compared to the same period in the previous year. Wall Street analysts are very optimistic and the stock trades at only 6 times their consensus estimates for the next fiscal year; however, we had not thought that the company was a good value. Read our discussion of Icahn and Take Two.

Lone Pine Capital was busy in the past week: the fund, managed by billionaire and Tiger Cub Stephen Mandel, issued two 13G filings. Lone Pine now owns 5.6 million shares of cloud computing related company Informatica Corporation (NASDAQ:INFA) and 2.2 million shares of pipeline and energy storage company SemGroup Corp (NYSE:SEMG). We looked at Lone Pine’s 13F filing for the second quarter of 2012 and it hadn’t owned either of these stocks at that time. Informatica trades at 30 times trailing earnings as the market demonstrates its excitement over the growth opportunities in cloud computing. The sell-side agrees that it will probably see strong earnings growth next year, with the stock trailing at a forward P/E of 20, but we had thought that was still a bit high and Informatica’s earnings per share are actually down so far this fiscal year. Learn more about Informatica. SemGroup is another industry play, as oil and gas activity in the U.S. is heating up and driving demand for more midstream infrastructure. As a result it’s also expected to see strong growth: in the first half of 2012, the company only earned 9 cents per share yet forward earnings estimates imply a P/E of 26. As with Informatica, we think that we’d avoid the stock based on pricing.

Billionaire Ken Griffin’s Citadel Investment Group reported a position of 2 million shares in Meritage Homes Corporation (NYSE:MTH), up from 1.2 million shares at the beginning of July. Like many stocks connected to housing, Meritage is up year to date (recording a 55% rise) as the market expects a rebound in the industry and a particularly strong recovery in the Sunbelt (where the company’s operations are concentrated). Its forward P/E is 24, and similarly to many of these other stocks that is based on quite a bit of analyst optimism. Investors should look at other homebuilding stocks instead if they want to play that thesis. Find out more about Citadel’s investment in Meritage.

Royce & Associates, a fund managed by Chuck Royce that tends to focus on mid-cap and small-cap stocks, increased its stake in Scholastic Corp (NASDAQ:SCHL) to a total of 3.1 million shares. The publishing business is more like the gaming industry than what the rest of these companies are in: beset with challenges based on how content is consumed. Scholatic’s most recent quarter was a less crucial part of its seasonal business, but with its losses higher than in the same period in 2011 and short sellers circling we don’t have enough confidence to buy it even at its current valuation of 11 times trailing earnings.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!